Quelle: stockhouse.com/companies/bullboard/v.xly/...c?postid=32501109
Ist von dem User ganz gut zusammengefasst: (für dt. Übersetzung kurz in Deepl einwerfen)
Auxly is FULLY FUNDED 2021 ! ! Oversubscribed and closed early at $0.37 per unit. That includes half warrants issued at $0.46.
The MMs know a great deal when they see one. How do they thanks us? By hittting us with yet another short attack.
Bite me you crooked bass tarts.
They were smart to take as much as they could this time cause there ain't no more to take.
Time to move forward into 2021.
My Q4-2020 Projection
In their Q3 filings Auxly reported Revenues in excess of $31mil for the 9 mos. ending Sept. 30, 2020.
$13.8 million in Q3-2020.
I’ve come across some pretty lofty projections for Auxly recently. I like to keep my expectations realistic. Auxly has been reported to have pulled down a 3.6% market share in cannabis sales in Canada in Q4-2020.
Stats Can reported
$270mil Oct.2020,
$260mil Nov.2020
and it’s reasonable to expect in excess of $250mil for Dec. 2020.
Based on this information if we estimate $750mil for sales in Canada for Auxly’s Q4 and multiply it by say 3% we can reasonably project possible revenues of $22,500,000 for Auxly in Q4.
This would represent an increase in revenues of approximately 50%-60% for Auxly over Q3-2020 revenues of $13.8mil. This far exceeds my previous sales growth estimate of 20%.
By this estimation, Auxly stands a good chance of reporting in excess of $50mil revs for FY-2020.
2021 Projection
Auxly has taken measures to cut costs while increasing production and expanding product offerings. Let’s take a look at what 2021 might bring us.
Assuming no growth in the Canadian Cannabis market for 2021 should account for COVID, I figure. So if we project sales of $250mil / mo that’s a potential market of $3billion for 2021. If we apply Auxly’s 3% market share, that suggests $90mil Revenues for 2021.
From what I see, Auxly is firmly on track to exceed $80mil revs for 2021 putting them in the realm of profitability by my calculations.
Some may consider this a modest estimate as the Legal Canadian Cannabis Market continues to expand in spite of COVID.
Auxly has been meeting or exceeding targets throughout 2020.
2021-H1 is Auxly management's target for reporting net profit.
2020-Q4 and FY Reports due March 31, 2021.
2021-Q1 Report due May 31, 2021.
With a creative, quality focused approach and sound application of market data analysis Auxly has launched into cannabis 2.0 and made significant strides with 1.0 offerings designed to appeal to a more decerning customer base that have been eagerly consumed.
Auxly is growing and rising up.
In my opinion, Auxly’s share price is far too low. Auxly warrants a much higher market cap at this time.
Now that finances for 2021 are secure we should see steady progress both in the business and the share price.
I could be wrong. Please correct me if I am.
Zurück
Weiter
Werbung
